| Sign In to gain access to subscriptions and/or personal tools. |
The palliative use of high-dose corticosteroids in three terminally ill patients with painGeriatrics and Extended Care, VA Medical Center, Phoenix, Arizona, RTA Hospice and Palliative Care, Phoenix, Arizona, Arizona College of Osteopathic Medicine, Glendale, Arizona, Adult Development and Aging, Arizona State University, Tempe, Arizona Corticosteroids are valuable pharmacological adjuncts utilized in the management of the diverse symptoms observed in terminally ill patients, including bone, neuropathic, and hepatic pain, asthenia and fatigue, and anorexia, and serve as an adjunct for the treatment of nausea and vomiting. If relief of suffering is the goal and mandate of palliative care, high-dose corticosteroids should be utilized in terminally ill patients for quickly reducing pain and improving quality of life for both patients and family members. In patients with a limited life expectancy of days to several weeks, long-term side effects will not occur and therefore should not preclude the continuous use of corticosteroids until the patients death. Three case studies are presented.
Key Words: corticosteroids dexamethasone methylprednisolone pain control prednisolone prednisone symptom management
American Journal of Hospice and Palliative Medicine®, Vol. 18, No. 5,
343-346 (2001) This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

